Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

NCT07644481 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

AML (Acute Myelogenous Leukemia)
Allogeneic Hematopoietic Stem Cell Transplantation Recipient

Interventions

DRUG: CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen

Sponsor

Institute of Hematology & Blood Diseases Hospital, China